Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.48 is 17% below its 5-year average of 4.19, near the low end of its 5-year range (1.09–19.26).
As of the fiscal period ended Tuesday, June 30, 2026. 11.65% below its 12-month average of 3.94.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.48.
QUICK RATIO (ACID-TEST)
3.48
QUICK RATIO (ACID-TEST) AVG TTM
3.94
QUICK RATIO (ACID-TEST) AVG 3Y
3.94
QUICK RATIO (ACID-TEST) AVG 5Y
4.19
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-11.65%
CURRENT VS 3Y AVG
-11.78%
CURRENT VS 5Y AVG
-17.03%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+3.87%
vs the sector median at left
Alpha Teknova, Inc.
Market Cap
$469.12M
Quick Ratio (Acid-Test)
3.48
TTM Avg
3.94
3Y Avg
3.94
5Y Avg
4.19
Market Cap
$470.68M
Quick Ratio (Acid-Test)
7.91
TTM Avg
4.78
3Y Avg
4.69
5Y Avg
6.49
Market Cap
$468.55M
Quick Ratio (Acid-Test)
1.07
TTM Avg
1.48
3Y Avg
1.43
5Y Avg
1.74
Market Cap
$466.84M
Quick Ratio (Acid-Test)
4.67
TTM Avg
9.07
3Y Avg
10.56
5Y Avg
11.63
Market Cap
$474.48M
Quick Ratio (Acid-Test)
121.97
TTM Avg
23.71
3Y Avg
19.95
5Y Avg
19.50
Market Cap
$474.97M
Quick Ratio (Acid-Test)
37.17
TTM Avg
24.09
3Y Avg
19.47
5Y Avg
19.38
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | $469.12M | 3.48 | 3.94 | 3.94 | 4.19 |
| Kamada Ltd. (KMDA)vs › | $468.77M | 2.29 | 2.21 | 1.73 | 2.24 |
| Arvinas, Inc. (ARVN)vs › | $470.68M | 7.91 | 4.78 | 4.69 | 6.49 |
| Cerus Corporation (CERS)vs › | $468.55M | 1.07 | 1.48 | 1.43 | 1.74 |
| Sight Sciences, Inc. (SGHT)vs › | $466.84M | 4.67 | 9.07 | 10.56 | 11.63 |
| Bright Minds Biosciences Inc. (DRUG)vs › | $474.48M | 121.97 | 23.71 | 19.95 | 19.50 |
| Contineum Therapeutics, Inc. (CTNM)vs › | $474.97M | 37.17 | 24.09 | 19.47 | 19.38 |
| Evolus, Inc. (EOLS)vs › | $484.45M | 1.28 | 1.88 | 1.90 | 1.89 |
| NRC Health (NRC)vs › | $454.11M | 0.65 | 0.55 | 0.77 | 1.10 |
| Puma Biotechnology, Inc. (PBYI)vs › | $484.31M | 2.64 | 1.69 | 1.64 | 1.50 |
Quick Ratio
3.48
Excludes inventory
Current Ratio
4.49
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 3.48 |
| 2026-03-31 | 3.60 |
| 2025-12-31 | 3.64 |
| 2025-09-30 | 4.27 |
| 2025-06-30 | 4.70 |
| 2025-03-31 | 4.71 |
| 2024-12-31 | 3.21 |
| 2024-09-30 | 3.94 |
| 2024-06-30 | 3.28 |
| 2024-03-31 | 3.92 |
| 2023-12-31 | 3.84 |
| 2023-09-30 | 4.75 |
| 2023-06-30 | 1.09 |
| 2023-03-31 | 4.33 |
| 2022-12-31 | 4.50 |
| 2022-09-30 | 4.85 |
| 2022-06-30 | 6.10 |
| 2022-03-31 | 6.77 |
| 2021-12-31 | 12.37 |
| 2021-09-30 | 17.19 |
| 2021-06-30 | 19.26 |
| 2021-03-31 | 3.69 |
| 2020-12-31 | 3.24 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
